Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline

March 9, 2023 Research and Development

Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …
News

AstraZeneca shares positive results from Imfinzi trial

March 9, 2023 Research and Development

Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …
News

New clinical trial aims to find new endometriosis treatment

March 8, 2023 Research and Development

A new clinical trial is set to begin shortly which will be a collaboration between the universities of Edinburgh, Aberdeen …
News

Wearable sensor helps detect heart attacks

March 7, 2023 Research and Development

RCE Technologies has developed a bracelet-like device that can measure levels of troponin-I in the patient’s blood, providing a more …
News

Abbott announces positive clinical study data for both TriClip system and MitraClip therapy

March 6, 2023 Research and Development

Abbott has announced positive data from two separate studies, which looked at its TriClip transcatheter edge-to-edge repair (TEER) system and …
News

Lilly receives approval for expanded indication for breast cancer therapy

March 6, 2023 Research and Development

Following positive data from Eli Lilly’s phase 3 monarchE trial, the FDA has granted approval for the expanded indication for …
News

Sanofi and Sobi celebrate completion of XTEND-Kids phase 3 study

March 2, 2023 Research and Development

A collaborative study between Sanofi and Sobi called XTEND-Kids phase 3 has finished, solidifying the first milestone needed for regulatory …
News

BioNxt Solutions signs clinical study agreement and commences clinical samples manufacture for Parkinson’s disease trial

March 1, 2023 Research and Development

BioNxt Solutions, a bioscience accelerator focused on next-generation drug formulations and delivery systems, has announced the finalisation of its comparative …
News

Sequana Medical shares positive results from phase 1 clinical trial

March 1, 2023 Research and Development

Sequana Medical has shared positive results from its phase 1 trial, CHIHUAHUA, assessing the safety and tolerability of a single …
News

CSL receives positive results from rare disease drug phase 3 trial

February 28, 2023 Research and Development

Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …
News

BiomX shares positive data from first bacteriophage trial

February 23, 2023 Research and Development

BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …
News

Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics

February 23, 2023 Research and Development

UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …
News

Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug

February 22, 2023 Research and Development

Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …
News

FDA grants approval to Beckley Psytech’s short-acting psychedelic trial

February 22, 2023 Research and Development

Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …
News

Pfizer likely to be first to gain FDA approval for new RSV vaccine

February 22, 2023 Research and Development

The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025